Global Atrial Fibrillation Market is Expected to Foresee Significant Growth During the Forecast Period. North America to Witness the Highest Growth
- Vikas Kumar
- July 16, 2022
- HEALTHCARE, NEWS
- Atrial Fibrillation Market, Atrial Fibrillation Market Forecast, Atrial Fibrillation Market Growth, Atrial Fibrillation Market Share, Atrial Fibrillation Market size, Atrial Fibrillation Market Trend
- 0 Comments
The Global Atrial Fibrillation Devices Market is expected to grow significantly by 2027 expanding at a reasonable CAGR of around 5% during the forecast period (2021-2027F). Atrial fibrillation is an irregular and often very rapid heart rhythm (arrhythmia) that can lead to blood clots in the heart. A-fib increases the risk of stroke, heart failure, and other heart-related complications.
For a detailed analysis of the Atrial Fibrillation Devices browse through https://univdatos.com/report/atrial-fibrillation-devices-market/
The rising geriatric population and increasing prevalence of cardiovascular diseases has resulted in an increase in cases of atrial fibrillation. Thus, creating demand for atrial fibrillation devices. According to research & publications, there are about 3 million people worldwide with pacemakers, and each year 600,000 pacemakers are implanted. Among them, the majority of patients are aged 60 years or older. Furthermore, an increasingly stressful lifestyle is also a cause of arrhythmia and in long run, it is responsible for the increasing cases of atrial fibrillation and increases the market size of atrial fibrillation devices.
Based on the product, the market is segmented into laboratory devices, ablation catheters, diagnostic catheters, and access devices. The ablation catheters are expected to witness significant market share in the atrial fibrillation device market. It is mainly due to the increasing demand for minimally invasive and painless procedures. Furthermore, the rapid advancements in technology also drive the market segment in the market. For instance, in June 2021, Acutus Medical launched AcQBlate Force Sensing Ablation System in Europe. AcQBlate FORCE shows physicians, in real-time, how much contact is being applied to the heart during ablation procedures.
For a detailed analysis of the product of Atrial fibrillation devices browse through https://univdatos.com/get-a-free-sample-form-php/?product_id=22580
Based on end-users, the market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals are expected to witness lucrative growth during the forecast period. This is mainly due to the presence of well-qualified professionals and their specialization in the treatment of multiple diseases. Furthermore, the rising number of heart diseases and the presence of diagnostic centers and other facilities under the same roof is responsible for the segmental growth in the atrial fibrillation device market.
Request for a Sample of the report browse through
For a better understanding of the market adoption of the atrial fibrillation device, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a significant market for atrial fibrillation devices due to the increasing number of arrhythmia cases in the region. Furthermore, the increasing geriatric population coupled with the frequent product launches in the region is responsible for the growth of North America in the atrial fibrillation device market.
For a detailed analysis of the market drivers of atrial fibrillation devices browse through https://univdatos.com/get-a-free-sample-form-php/?product_id=22580
Johnson & Johnson, MicroPort Scientific Corporation, Boston Scientific Corporation, St. Jude Medical Inc., Medtronic plc, Abbott Laboratories, Biotronik SE & Co. KG, Koninklijke Philips N.V., Siemens AG, and AtriCure Inc. are some of the key players operating in the global atrial fibrillation devices market. Several M&As along with partnerships have been undertaken by these players to develop various types of atrial fibrillation devices.
Global Atrial Fibrillation Devices Market Segmentation
Market Insight, by Product
Market Insight, by End-users
- Ambulatory Surgical Centers
Market Insight, by Region
- North America
- United States
- Rest of North America
- United Kingdom
- Rest of Europe
- Rest of Asia-Pacific
- Rest of World
Top Company Profiles
• Johnson & Johnson
• MicroPort Scientific Corporation
• Boston Scientific Corporation
• St. Jude Medical Inc.
• Medtronic plc
• Abbott Laboratories
• Biotronik SE & Co. KG
• Koninklijke Philips N.V.
• Siemens AG
• AtriCure Inc.